3PBiovian Capabilities Update October 2026: Large Molecule

Built to Advance Next-Gen Biotherapeutics

Integrated Development and Manufacturing Capabilities for Biologics and Advanced Therapies

Join 3PBIOVIAN, a leading CDMO supporting customers from preclinical and clinical supply through to full-scale commercial manufacturing.

In this session, 3PBIOVIAN will provide a practical overview of our current capabilities and available capacity across our sites in Spain and Finland. We will showcase our capabilities in microbial and mammalian expression systems, plasmid DNA, viral vectors including AAV and adenovirus for gene therapy, as well as fill & finish services for recombinant proteins and viral vectors. We will also highlight the experienced teams behind these capabilities and how their expertise enables us to support customers with flexible and integrated solutions across the development and manufacturing lifecycle.

Whether you are actively outsourcing a program, looking to secure additional manufacturing capacity, or planning for future pipeline needs, this session will provide a clear view of how 3PBIOVIAN can help advance your programs with the capabilities, capacity, and expertise needed to support them at every stage.